These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5309465)

  • 1. Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man.
    Tauraso NM; Gleckman R; Pedreira FA; Sabbaj J; Yahwak R; Madoff MA
    Bull World Health Organ; 1969; 41(3):507-16. PubMed ID: 5309465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.
    Knight V; Couch RB; Douglas RG; Tauraso NM
    Bull World Health Organ; 1971; 45(6):767-71. PubMed ID: 5317012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
    Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine.
    Sonoguchi T
    Bull World Health Organ; 1969; 41(3):517-23. PubMed ID: 5309466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
    Nicholson KG; Colegate AE; Podda A; Stephenson I; Wood J; Ypma E; Zambon MC
    Lancet; 2001 Jun; 357(9272):1937-43. PubMed ID: 11425416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Hobson D; Baker FA; Curry RL; Beare AS; Massey PM
    J Hyg (Lond); 1973 Dec; 71(4):641-7. PubMed ID: 4588772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization.
    Phillips CA; Forsyth BR; Christmas WA; Gump DW; Whorton EB; Rogers I; Rudin A
    J Infect Dis; 1970; 122(1):26-32. PubMed ID: 5433710
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
    N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies.
    Hauge S; Madhun A; Cox RJ; Haaheim LR
    Clin Vaccine Immunol; 2007 Aug; 14(8):978-83. PubMed ID: 17596426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EFFECT OF DOSAGE ON ANTIBODY RESPONSE TO POLYVALENT INFLUENZA VIRUS VACCINE IN AN AGED POPULATION.
    SASLAW S; CARLISLE HN
    Am J Med Sci; 1964 Sep; 248():273-84. PubMed ID: 14210303
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature.
    Halperin W; Weiss WI; Altman R; Diamond MA; Black KJ; Iaci AW; Black HC; Goldfield M
    Am J Public Health; 1979 Dec; 69(12):1247-51. PubMed ID: 507256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Hobson D; Baker FA; Chivers CP; Reed SE; Sharp D
    J Hyg (Lond); 1970 Sep; 68(3):369-78. PubMed ID: 4917915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intradermally administered A2 Hong Kong vaccine.
    Foy HM; Sealey L; Cooney MK; Bor E
    JAMA; 1970 Jul; 213(1):130. PubMed ID: 5467968
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial.
    Liebowitz D; Lindbloom JD; Brandl JR; Garg SJ; Tucker SN
    Lancet Infect Dis; 2015 Sep; 15(9):1041-1048. PubMed ID: 26333337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.